PetVivo Holdings Inc (OTCPK:PETVW)
$ 0.0051 (0%) Market Cap: 0 Enterprise Value: 0 PE Ratio: 0 PB Ratio: 8.42 GF Score: 35/100

Q2 2026 PetVivo Holdings Inc Earnings Call Transcript

Nov 14, 2025 / 10:00 PM GMT

Key Points

Positve
  • PetVivo Holdings Inc (PETV) reported a 51% increase in total revenue for the quarter, reaching $303,000, marking it as their highest revenue-generating fiscal second quarter on record.
  • The company's flagship product, Spring with osteo cushion technology, has been adopted by over 1,200 veterinary clinics across all 50 states, with international expansion into Europe and Mexico.
  • The introduction of Precise PRP for dogs and horses has generated increased revenue, with expectations for accelerated growth in the equine market.
  • PetVivo Holdings Inc (PETV) has significantly reduced its total liabilities by 79%, from $5.1 million to $1.1 million, due to the extinguishment of derivative liabilities and conversion of convertible notes to common stock.
  • The company has qualified to trade on the OTCQX Best Market, enhancing its visibility and liquidity within the investment community.
Negative
  • Despite revenue growth, PetVivo Holdings Inc (PETV) reported a net loss of $3 million for the quarter, attributed to increased interest expenses from debt discount.
  • The gross margin decreased due to the new Precise PRP product, which carries a smaller margin, impacting overall profitability.
  • Operating expenses, although reduced by 3%, remain high at $2.3 million, indicating ongoing financial challenges.
  • The adoption of new products like Spring and Precise PRP is slow, with a learning curve for veterinarians, particularly in the companion animal market.
  • The company faces challenges in achieving corporate-wide adoption of its products within large veterinary groups, as decision-making is often left to individual veterinarians.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PETV.PK - PetVivo Holdings Inc
Q2 2026 PetVivo Holdings Inc Earnings Call
Nov 14, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, everyone.

Thank you for joining us today to discuss our results for our second quarter of fiscal 2026, which ended on September 30th, 2025.

Hosting the call today is our Chief Executive Officer, John Lai, our Chief Financial Officer, Gary Lowenthal, our commercial operations advisor, Mike Eldred, and myself, John Dolan, Pet Vivo's Chief Business Development Officer and General Counsel.

Following our remarks, we'll open the call for your questions. Then before we conclude today's call, I will provide some important cautions regarding the forward-looking statements made during the call.

Before we begin, I'd like to remind everyone that the call is being recorded in order to make it
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot